Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov version as v3.8.1 instead of v3.8.0. The study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T02:25:00.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial’s full study record is displayed, covering its design, eligibility criteria, treatment arms, outcomes, and participating locations, along with results and study documents. It replaces the previous forbidden-error page.
    Difference
    78%
    Check dated 2026-11-11T01:41:45.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:48:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    An NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” across NIH content. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:49:29.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T23:44:18.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previous study record content and attached documents; users cannot view the study details.
    Difference
    20%
    Check dated 2026-09-23T01:08:55.000Z thumbnail image

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.